Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Martinetti

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 29, 1998
Neuron-specific enolase evaluation in patients with neuroblastomaS Massaron, E Seregni, R Luksch, et al.
Anticancer Research|September 3, 1999
Premenopausal breast cancer patients treated with a gonadotropin-releasing hormone analog alone or in combination with an aromatase inhibitor: a comparative endocrine studyL Celio, A Martinetti, L Ferrari, et al.
Tumori|November 6, 2001
A feasibility study using polychemotherapy (cisplatin + vindesine + dacarbazine) plus interferon-alpha or monochemotherapy with dacarbazine plus interferon-alpha in metastatic melanomaE Bajetta, M Del Vecchio, M Vitali, et al.
British Journal of Cancer|October 1, 1995
Endocrinological and clinical evaluation of exemestane, a new steroidal aromatase inhibitorN Zilembo, C Noberasco, E Bajetta, et al.
The International Journal of Biological Markers|January 14, 2005
Accuracy and clinical correlates of two different methods for chromogranin A assay in neuroendocrine tumorsL Ferrari, E Seregni, G Lucignani, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|February 20, 2010
Treatment with tandem [(90)Y]DOTA-TATE and [(177)Lu] DOTA-TATE of neuroendocrine tumors refractory to conventional therapy: preliminary resultsE Seregni, M Maccauro, A Coliva, et al.
European Journal of Cancer (Oxford, England : 1990)|August 17, 1999
Double-blind, randomised, multicentre endocrine trial comparing two letrozole doses, in postmenopausal breast cancer patientsE Bajetta, N Zilembo, M Dowsett, et al.
Eating and Weight Disorders : EWD|June 28, 2006
Amenorrhea after weight recover in anorexia nervosa: role of body composition and endocrine abnormalitiesF Jacoangeli, S Masala, F Staar Mezzasalma, et al.
International Journal of Oncology|April 30, 2011
Effects of aromatase complex selective inhibition on insulin-like growth factor 1 and insulin-like growth factor binding protein 3 circulating levels in breast cancerL Ferrari, E Bajetta, E Seregni, et al.
Endocrine-Related Cancer|December 23, 2004
Osteoprotegerin and osteopontin serum values in postmenopausal advanced breast cancer patients treated with anastrozoleA Martinetti, E Bajetta, L Ferrari, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 29, 1998
Neuron-specific enolase evaluation in patients with neuroblastomaS Massaron, E Seregni, R Luksch, et al.
Anticancer Research|September 3, 1999
Premenopausal breast cancer patients treated with a gonadotropin-releasing hormone analog alone or in combination with an aromatase inhibitor: a comparative endocrine studyL Celio, A Martinetti, L Ferrari, et al.
Tumori|November 6, 2001
A feasibility study using polychemotherapy (cisplatin + vindesine + dacarbazine) plus interferon-alpha or monochemotherapy with dacarbazine plus interferon-alpha in metastatic melanomaE Bajetta, M Del Vecchio, M Vitali, et al.
British Journal of Cancer|October 1, 1995
Endocrinological and clinical evaluation of exemestane, a new steroidal aromatase inhibitorN Zilembo, C Noberasco, E Bajetta, et al.
The International Journal of Biological Markers|January 14, 2005
Accuracy and clinical correlates of two different methods for chromogranin A assay in neuroendocrine tumorsL Ferrari, E Seregni, G Lucignani, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|February 20, 2010
Treatment with tandem [(90)Y]DOTA-TATE and [(177)Lu] DOTA-TATE of neuroendocrine tumors refractory to conventional therapy: preliminary resultsE Seregni, M Maccauro, A Coliva, et al.
European Journal of Cancer (Oxford, England : 1990)|August 17, 1999
Double-blind, randomised, multicentre endocrine trial comparing two letrozole doses, in postmenopausal breast cancer patientsE Bajetta, N Zilembo, M Dowsett, et al.
Eating and Weight Disorders : EWD|June 28, 2006
Amenorrhea after weight recover in anorexia nervosa: role of body composition and endocrine abnormalitiesF Jacoangeli, S Masala, F Staar Mezzasalma, et al.
International Journal of Oncology|April 30, 2011
Effects of aromatase complex selective inhibition on insulin-like growth factor 1 and insulin-like growth factor binding protein 3 circulating levels in breast cancerL Ferrari, E Bajetta, E Seregni, et al.
Endocrine-Related Cancer|December 23, 2004
Osteoprotegerin and osteopontin serum values in postmenopausal advanced breast cancer patients treated with anastrozoleA Martinetti, E Bajetta, L Ferrari, et al.
Pageof 6